How Will a Trump or Clinton Presidency Affect Your Portfolio?

Do you own Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) or TransCanada Corporation (TSX:TRP)(NYSE:TRP) shares? Then pay attention to this election cycle.

| More on:
The Motley Fool

As August turns to September, what certainly seems like the longest presidential race in history finally enters the home stretch. We’re just a little over 60 days away from the election itself and fewer than 30 days away from the first official debate between Republican Donald Trump and Democrat Hillary Clinton.

Although Clinton does have a sizable lead over Trump in current polls, there are still plenty of reasons folks shouldn’t count the famous billionaire real estate developer out. Trump has been an underdog this whole election; he’s proven that he can come back from long odds.

There are threats to Clinton as well, including constant questions about her health as well as the email scandal–a story that just won’t go away.

Trump is hardly a perfect candidate either. Although he has toned down some of his anti-immigration rhetoric, many voters still refuse to give him a chance because of these strong opinions. This could end up causing him the White House.

This election isn’t just an entertaining side show for Canadian investors. It is likely to impact our portfolios in at least a small way. Let’s take a closer look at what a win for each candidate will mean for us.

Trump wins

A likely first move if Donald Trump gets elected is the weakening of the U.S. dollar. This is bad news for Canadian exporters, but good news for importers.

Our retailers are the easy winners in such a scenario, assuming the weakness in the U.S. dollar lasts. Dollarama Inc. (TSX: DOL) would be a particular winner. The company responded to the recent weakness in the Canadian dollar by raising the prices on many of its imported items, passing on the costs to shoppers.

It proved to be a successful strategy; results in recent quarters were better than ever. But at the same time it may be hard to continue to pass through these price increases. With items in stores reaching as high as $4 each, at what point do customers start feeling a little alienated?

Another potential winner if Trump wins is TransCanada Corporation (TSX: TRP)(NYSE: TRP). The company’s proposed Keystone XL pipeline was struck down by current president Obama back in 2015 after years of environmentalists fighting the expansion.

Trump has not only promised to take another look at TransCanada’s application, but he’s actually made several campaign promises to approve Keystone XL. If Trump is elected, look for TransCanada shares to rally.

Clinton wins

Hillary Clinton has vowed to be tough on pharmaceutical companies about rising drug costs. If she’s elected, it’s likely that both Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) and Concordia International Corp (TSX:CXR)(NASDAQ:CXRX) will get hit again.

Neither of these companies can really afford the added scrutiny of the White House making an example of them. Both are down substantially from their peaks as investors realized there were serious warts on each company.

Valeant has been accused of using innovative accounting, and Concordia has been deemed guilty by association. Both companies are also dealing with a large amount of debt, which could be potentially fatal. The last thing they need is a Clinton White House forcing them to accept lower prices for their drugs.

It is also possible a Hillary Clinton presidency is bearish for U.S. bonds. Clinton plans to spend more aggressively than Trump, investing in infrastructure, medicare, social security, and other programs that cost money. The government will borrow to make these things happen.

Eventually, investors will grow weary of all the borrowing the U.S. government does, which could cause the prices of treasuries to fall, increasing the yield. Yields from other bonds would then increase as well, bringing up interest rates across the board.

Conclusion

Ultimately, these are all guesses. Nobody really knows what will happen in the future. But whether Clinton wins or Trump finds a way to come back, each candidate will have an effect on your portfolio. The only question is how much it’ll matter.

Fool contributor Nelson Smith has no position in any stocks mentioned. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Dividend Stocks

Two seniors float in a pool.
Dividend Stocks

This Stock Could Quietly Pay for Your Next Vacation, Every Year

Turn Canadian grocery trips into travel cash with an investment in Choice Properties REIT earning a 5.2% yield, paid monthly...

Read more »

crisis concept, falling stairs
Dividend Stocks

This Canadian Dividend Stock is Down 15%: Should You Buy the Dip?

This company has increased its dividend annually for the past 26 years.

Read more »

Hourglass and stock price chart
Dividend Stocks

The Most Boring Stock on the TSX Might Be One of Its Smartest Buys

CNR stock does not offer explosive growth or a massive dividend yield. However, its stability and track record can make…

Read more »

A close up color image of a small green plant sprouting out of a pile of Canadian dollar coins "loonies."
Dividend Stocks

3 Canadian Dividend Giants I’d Buy With Rates on Hold

Focusing on dividend giants while interest rates are on hold is a prudent strategy for income investors.

Read more »

Retirees sip their morning coffee outside.
Dividend Stocks

These 3 Canadian Dividend Stocks Are Great for Retirees

Given their strong financials, consistent dividend payouts, and healthy growth prospects, these three Canadian stocks are ideal for retirees.

Read more »

rising arrow with flames
Dividend Stocks

The Market’s On Fire — But Should You Be Buying Right Now?

Despite the hot market, investors could still invest selectively in quality businesses. Diversify and dollar-cost average over time to mitigate…

Read more »

man with shovel stands by a hole
Dividend Stocks

TD Just Put $150 Billion Behind Canada’s Next Investment Boom. Should You Buy the Stock?

Instead of betting on which mega-project wins, consider a picks-and-shovels play on the bank that earns interest and fees on…

Read more »

telecom towers concept for wireless technology
Dividend Stocks

Bell Just Made a $52.5 Billion Bet on AI. So Is BCE Stock Finally a Buy?

BCE’s ambitious AI hub plan could reinvent the telecom’s growth story, but it first requires years of heavy spending.

Read more »